Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2015 (2015), Article ID 578423, 8 pages
http://dx.doi.org/10.1155/2015/578423
Review Article

Human Papillomavirus Infection, Infertility, and Assisted Reproductive Outcomes

1The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, NY 10021, USA
2Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY 10021, USA

Received 28 August 2015; Accepted 30 September 2015

Academic Editor: Cormac G. M. Gahan

Copyright © 2015 Nigel Pereira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Pagliusi and M. T. Aguado, “Efficacy and other milestones for human papillomavirus vaccine introduction,” Vaccine, vol. 23, no. 5, pp. 569–578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. R. Pagliusi and S. M. Garland, “International standard reagents for HPV detection,” Disease Markers, vol. 23, no. 4, pp. 283–296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Stanley, “Immunobiology of HPV and HPV vaccines,” Gynecologic Oncology, vol. 109, supplement 2, pp. S15–S21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Souho, M. Benlemlih, B. Bennani, and D. M. Harper, “Human papillomavirus infection and fertility alteration: a systematic review,” PLoS ONE, vol. 10, no. 5, Article ID e0126936, 2015. View at Publisher · View at Google Scholar
  5. S. D. Spandorfer, A. M. Bongiovanni, S. Fasioulotis, Z. Rosenwaks, W. J. Ledger, and S. S. Witkin, “Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome,” Fertility and Sterility, vol. 86, no. 3, pp. 765–767, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. E. Markowitz, V. Tsu, S. L. Deeks et al., “Human papillomavirus vaccine introduction—the first five years,” Vaccine, vol. 30, supplement 5, pp. F139–F148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Noronha, L. E. Markowitz, and E. F. Dunne, “Systematic review of human papillomavirus vaccine coadministration,” Vaccine, vol. 32, no. 23, pp. 2670–2674, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. E. F. Dunne, L. E. Markowitz, M. Saraiya et al., “CDC grand rounds: reducing the burden of HPV-associated cancer and disease,” Morbidity and Mortality Weekly Report, vol. 63, no. 4, pp. 69–72, 2014. View at Google Scholar · View at Scopus
  9. A. Jemal, E. P. Simard, C. Dorell et al., “Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels,” Journal of the National Cancer Institute, vol. 105, no. 3, pp. 175–201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Jeudin, E. Liveright, M. G. Del Carmen, and R. B. Perkins, “Race, ethnicity, and income factors impacting human papillomavirus vaccination rates,” Clinical Therapeutics, vol. 36, no. 1, pp. 24–37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. W. Chesson, D. U. Ekwueme, M. Saraiya, M. Watson, D. R. Lowy, and L. E. Markowitz, “Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States,” Vaccine, vol. 30, no. 42, pp. 6016–6019, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Castellsagué, “Natural history and epidemiology of HPV infection and cervical cancer,” Gynecologic Oncology, vol. 110, supplement 2, no. 3, pp. S4–S7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. K. Kjaer, B. Chackerian, A. J. C. van den Brule et al., “High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse),” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 2, pp. 101–106, 2001. View at Google Scholar · View at Scopus
  14. A. Antonsson, S. Karanfilovska, P. G. Lindqvist, and B. G. Hansson, “General acquisition of human papillomavirus infections of skin occurs in early infancy,” Journal of Clinical Microbiology, vol. 41, no. 6, pp. 2509–2514, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Muñoz, F. Méndez, H. Posso et al., “Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results,” Journal of Infectious Diseases, vol. 190, no. 12, pp. 2077–2087, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Vaccarella, R. Herrero, M. Dai et al., “Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 11, pp. 2148–2153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Stanley, “Pathology and epidemiology of HPV infection in females,” Gynecologic Oncology, vol. 117, supplement 2, pp. S5–S10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. M. Clifford, M. A. G. Gonçalves, and S. Franceschi, “Human papillomavirus types among women infected with HIV: a meta-analysis,” AIDS, vol. 20, no. 18, pp. 2337–2344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Garcia-Chacon, S. F. Velasco-Ramirez, L. Flores-Romo, and A. Daneri-Navarro, “Immunobiology of HPV infection,” Archives of Medical Research, vol. 40, no. 6, pp. 443–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Stanley, L. Gissmann, and D. Nardelli-Haefliger, “Immunobiology of human papillomavirus infection and vaccination—implications for second generation vaccines,” Vaccine, vol. 26, supplement 10, pp. K62–K67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Committee on Practice Bulletins—Gynecology, “ACOG practice bulletin number 131: screening for cervical cancer,” Obstetrics & Gynecology, vol. 120, no. 5, pp. 1222–1238, 2012. View at Publisher · View at Google Scholar
  22. D. Saslow, D. Solomon, H. W. Lawson et al., “American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer,” American Journal of Clinical Pathology, vol. 137, no. 4, pp. 516–542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. K. S. Cuschieri, H. A. Cubie, M. W. Whitley et al., “Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study,” Journal of Clinical Pathology, vol. 58, no. 9, pp. 946–950, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. K.-L. Liaw, A. Hildesheim, R. D. Burk et al., “A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types,” The Journal of Infectious Diseases, vol. 183, no. 1, pp. 8–15, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Cobos, J. A. Figueroa, L. Mirandola et al., “The role of Human Papilloma Virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review,” International Reviews of Immunology, vol. 33, no. 5, pp. 383–401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. CDC, Human Papillomavirus (HPV)-Associated Cancers, US Department of Health and Human Services, CDC, Atlanta, Ga, USA, 2013, http://www.cdc.gov/cancer/hpv/statistics/cases.htm.
  27. D. P. Zandberg, R. Bhargava, S. Badin, and K. J. Cullen, “The role of human papillomavirus in nongenital cancers,” CA: A Cancer Journal for Clinicians, vol. 63, no. 1, pp. 57–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Fakhry, W. H. Westra, S. Li et al., “Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial,” Journal of the National Cancer Institute, vol. 100, no. 4, pp. 261–269, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. C. R. Ragin and E. Taioli, “Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis,” International Journal of Cancer, vol. 121, no. 8, pp. 1813–1820, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. K. K. Ang, J. Harris, R. Wheeler et al., “Human papillomavirus and survival of patients with oropharyngeal cancer,” The New England Journal of Medicine, vol. 363, no. 1, pp. 24–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Srinivasan, E. Taioli, and C. C. Ragin, “Human papillomavirus type 16 and 18 in primary lung cancers—a meta-analysis,” Carcinogenesis, vol. 30, no. 10, pp. 1722–1728, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Ciotti, L. Giuliani, V. Ambrogi et al., “Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer,” Oncology Reports, vol. 16, no. 1, pp. 183–189, 2006. View at Google Scholar · View at Scopus
  33. A. M. Aglianò, A. Gradilone, P. Gazzaniga et al., “High frequency of human papillomavirus detection in urinary bladder cancer,” Urologia Internationalis, vol. 53, no. 3, pp. 125–129, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Kapranos, E. Petrakou, C. Anastasiadou, and D. Kotronias, “Detection of herpes simplex virus, cytomegalovirus, and Epstein-Barr virus in the semen of men attending an infertility clinic,” Fertility and Sterility, vol. 79, supplement 3, pp. 1566–1570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. B. G. Bachir and K. Jarvi, “Infectious, inflammatory, and immunologic conditions resulting in male infertility,” Urologic Clinics of North America, vol. 41, no. 1, pp. 67–81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Gizzo, B. Ferrari, M. Noventa et al., “Male and couple fertility impairment due to HPV-DNA sperm infection: update on molecular mechanism and clinical impact—systematic review,” BioMed Research International, vol. 2014, Article ID 230263, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. C. E. Depuydt, A. M. Criel, I. H. Benoy, M. Arbyn, A. J. Vereecken, and J. J. Bogers, “Changes in type-specific human papillomavirus load predict progression to cervical cancer,” Journal of Cellular and Molecular Medicine, vol. 16, no. 12, pp. 3096–3104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Schillaci, G. Capra, C. Bellavia et al., “Detection of oncogenic human papillomavirus genotypes on spermatozoa from male partners of infertile couples,” Fertility and Sterility, vol. 100, no. 5, pp. 1236–1240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. M. Lai, F.-P. Yang, and C. C. Pao, “Human papillomavirus deoxyribonucleic acid and ribonucleic acid in seminal plasma and sperm cells,” Fertility and Sterility, vol. 65, no. 5, pp. 1026–1030, 1996. View at Google Scholar · View at Scopus
  40. O. Olatunbosun, H. Deneer, and R. Pierson, “Human papillomavirus DNA detection in sperm using polymerase chain reaction,” Obstetrics and Gynecology, vol. 97, no. 3, pp. 357–360, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Bezold, J. A. Politch, N. B. Kiviat, J. M. Kuypers, H. Wolff, and D. J. Anderson, “Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia,” Fertility and Sterility, vol. 87, no. 5, pp. 1087–1097, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. C. M. Nielson, R. Flores, R. B. Harris et al., “Human papillomavirus prevalence and type distribution in male anogenital sites and semen,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 6, pp. 1107–1114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. C. M. Nielson, R. B. Harris, R. Flores et al., “Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 4, pp. 1077–1083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Aynaud, J.-D. Poveda, B. Huynh, A. Guillemotonia, and R. Barrasso, “Frequency of herpes simplex virus, cytomegalovirus and human papillomavirus DNA in semen,” International Journal of STD and AIDS, vol. 13, no. 8, pp. 547–550, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Pérez-Andino, C. B. Buck, and K. Ribbeck, “Adsorption of human papillomavirus 16 to live human sperm,” PLoS ONE, vol. 4, no. 6, Article ID e5847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Foresta, A. Garolla, D. Zuccarello et al., “Human papillomavirus found in sperm head of young adult males affects the progressive motility,” Fertility and Sterility, vol. 93, no. 3, pp. 802–806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Garolla, D. Pizzol, and C. Foresta, “The role of human papillomavirus on sperm function,” Current Opinion in Obstetrics and Gynecology, vol. 23, no. 4, pp. 232–237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Foresta, C. Patassini, A. Bertoldo et al., “Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa,” PLoS ONE, vol. 6, no. 3, Article ID e15036, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. M. Lai, Y. K. Soong, J. F. Lee, F.-P. Yang, H. Y. Huang, and C. C. Pao, “The effect of human papillomavirus infection on sperm cell motility,” Fertility and Sterility, vol. 67, no. 6, pp. 1152–1155, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. D. A. Connelly, P. J. Chan, W. C. Patton, and A. King, “Human sperm deoxyribonucleic acid fragmentation by specific types of papillomavirus,” American Journal of Obstetrics & Gynecology, vol. 184, no. 6, pp. 1068–1070, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. J. E. Brossfield, P. J. Chan, W. C. Patton, and A. King, “Tenacity of exogenous human papillomavirus DNA in sperm washing,” Journal of Assisted Reproduction and Genetics, vol. 16, no. 6, pp. 325–328, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Garolla, A. Lenzi, G. Pal et al., “Human papillomavirus sperm infection and assisted reproduction: a dangerous hazard with a possible safe solution,” Human Reproduction, vol. 27, no. 4, pp. 967–973, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Foresta, D. Pizzol, A. Moretti, L. Barzon, G. Pal, and A. Garolla, “Clinical and prognostic significance of human papillomavirus DNA in the sperm or exfoliated cells of infertile patients and subjects with risk factors,” Fertility and Sterility, vol. 94, no. 5, pp. 1723–1727, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Foresta, M. Noventa, L. De Toni, S. Gizzo, and A. Garolla, “HPV-DNA sperm infection and infertility: from a systematic literature review to a possible clinical management proposal,” Andrology, vol. 3, no. 2, pp. 163–173, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. C. A. Lee, C. T. F. Huang, A. King, and P. J. Chan, “Differential effects of human papillomavirus DNA types on p53 tumor-suppressor gene apoptosis in sperm,” Gynecologic Oncology, vol. 85, no. 3, pp. 511–516, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. M. A. M. Rintala, S. E. Grénman, P. P. Pöllänen, J. J. O. Suominen, and S. M. Syrjänen, “Detection of high-risk HPV DNA in semen and its association with the quality of semen,” International Journal of STD and AIDS, vol. 15, no. 11, pp. 740–743, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. P. J. Chan, B. C. Su, T. Kalugdan, I. M. Seraj, D. R. Tredway, and A. King, “Human papillomavirus gene sequences in washed human sperm deoxyribonucleic acid,” Fertility and Sterility, vol. 61, no. 5, pp. 982–985, 1994. View at Google Scholar · View at Scopus
  58. P. J. Chan, T. Kalugdan, B. C. Su et al., “Sperm as a noninvasive gene delivery system for preimplantation embryos,” Fertility and Sterility, vol. 63, no. 5, pp. 1121–1124, 1995. View at Google Scholar · View at Scopus
  59. R. L. Rombaldi, E. P. Serafini, J. Mandelli, E. Zimmermann, and K. P. Losquiavo, “Transplacental transmission of human papillomavirus,” Virology Journal, vol. 5, article 106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. P. J. Chan, B. C. Su, D. R. Tredway, M. Seraj, I. M. Seraj, and A. King, “Uptake of exogenous human papilloma virus l1 DNA by oocytes and detection by the polymerase chain reaction,” Journal of Assisted Reproduction and Genetics, vol. 9, no. 6, pp. 531–533, 1992. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Cabrera, P. J. Chan, T. H. Kalugdan, and A. King, “Transfection of the inner cell mass and lack of a unique DNA sequence affecting the uptake of exogenous DNA by sperm as shown by dideoxy sequencing analogues,” Journal of Assisted Reproduction and Genetics, vol. 14, no. 2, pp. 120–124, 1997. View at Publisher · View at Google Scholar · View at Scopus
  62. H. You, Y. Liu, M. J. Carey, C. L. Lowery, and P. L. Hermonat, “Defective 3A trophoblast-endometrial cell adhesion and altered 3A growth and survival by human papillomavirus type 16 oncogenes,” Molecular Cancer Research, vol. 1, no. 1, pp. 25–31, 2002. View at Google Scholar · View at Scopus
  63. J. H. Calinisan, S. R. Chan, A. King, and P. J. Chan, “Human papillomavirus and blastocyst apoptosis,” Journal of Assisted Reproduction and Genetics, vol. 19, no. 3, pp. 132–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. A. A. Henneberg, W. C. Patton, J. D. Jacobson, and P. J. Chan, “Human papilloma virus DNA exposure and embryo survival is stage-specific,” Journal of Assisted Reproduction and Genetics, vol. 23, no. 6, pp. 255–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. L. M. Gomez, Y. Ma, C. Ho, C. M. McGrath, D. B. Nelson, and S. Parry, “Placental infection with human papillomavirus is associated with spontaneous preterm delivery,” Human Reproduction, vol. 23, no. 3, pp. 709–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Noventa, A. Andrisani, S. Gizzo, G. B. Nardelli, and G. Ambrosini, “Is it time to shift the attention on early stages embryo development to avoid inconclusive evidence on HPV-related infertility: debate and proposal,” Reproductive Biology and Endocrinology, vol. 12, article 48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. W. Eppel, C. Worda, P. Frigo, M. Ulm, E. Kucera, and K. Czerwenka, “Human papillomavirus in the cervix and placenta,” Obstetrics and Gynecology, vol. 96, no. 3, pp. 337–341, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Matovina, K. Husnjak, N. Milutin, S. Ciglar, and M. Grce, “Possible role of bacterial and viral infections in miscarriages,” Fertility and Sterility, vol. 81, no. 3, pp. 662–669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. L. J. Hong, B. T. Oshiro, and P. J. Chan, “HPV-16 exposed mouse embryos: a potential model for pregnancy wastage,” Archives of Gynecology and Obstetrics, vol. 287, no. 6, pp. 1093–1097, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. P. L. Hermonat, L. Han, P. J. Wendel et al., “Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens,” Virus Genes, vol. 14, no. 1, pp. 13–17, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Skoczyński, A. Goździcka-Józefiak, and A. Kwaśniewska, “Prevalence of human papillomavirus in spontaneously aborted products of conception,” Acta Obstetricia et Gynecologica Scandinavica, vol. 90, no. 12, pp. 1402–1405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Conde-Ferráez, A. D. A. Chan May, J. R. Carrillo-Martínez, G. Ayora-Talavera, and M. D. R. González-Losa, “Human papillomavirus infection and spontaneous abortion: a case-control study performed in Mexico,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 170, no. 2, pp. 468–473, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. C. E. Depuydt, L. Verstraete, M. Berth et al., “Human papillomavirus positivity in women undergoing intrauterine insemination has a negative effect on pregnancy rates,” Gynecologic and Obstetric Investigation, 2015. View at Publisher · View at Google Scholar
  74. D. van Hamont, L. H. C. Nissen, A. G. Siebers et al., “Abnormal cervical cytology in women eligible for IVF,” Human Reproduction, vol. 21, no. 9, pp. 2359–2363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Abdullgaffar, M. O. Kamal, and A. Hasoub, “The prevalence of abnormal cervical cytology in women with infertility,” Diagnostic Cytopathology, vol. 38, no. 11, pp. 791–794, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Tanaka, A. Karube, H. Kodama, J. Fukuda, and T. Tanaka, “Mass screening for human papillomavirus type 16 infection in infertile couples,” The Journal of Reproductive Medicine, vol. 45, no. 11, pp. 907–911, 2000. View at Google Scholar · View at Scopus
  77. A. Perino, L. Giovannelli, R. Schillaci et al., “Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes,” Fertility and Sterility, vol. 95, no. 5, pp. 1845–1848, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Comar, L. Monasta, N. Zanotta, L. Vecchi Brumatti, G. Ricci, and G. Zauli, “Human papillomavirus infection is associated with decreased levels of GM-CSF in cervico-vaginal fluid of infected women,” Journal of Clinical Virology, vol. 58, no. 2, pp. 479–481, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Wang, C. Wang, J. Qiao, L. Wang, and S. Liang, “Relationship of cytopathology and cervical infection to outcome of in-vitro fertilization and embryo transfer,” International Journal of Gynecology and Obstetrics, vol. 101, no. 1, pp. 21–26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Yang, Y. Wang, J. Qiao, P. Liu, L. Geng, and Y.-L. Guo, “Does human papillomavirus infection do harm to in-vitro fertilization outcomes and subsequent pregnancy outcomes?” Chinese Medical Journal, vol. 126, no. 4, pp. 683–687, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. H. Park, S. W. Lee, I. H. Lee et al., “Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery,” Virology Journal, vol. 9, article 80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Cho, K.-J. Min, H.-R. Hong et al., “High-risk human papillomavirus infection is associated with premature rupture of membranes,” BMC Pregnancy and Childbirth, vol. 13, article 173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. U. Bonde, J. S. Joergensen, O. Mogensen, and R. F. Lamont, “The potential role of HPV vaccination in the prevention of infectious complications of pregnancy,” Expert Review of Vaccines, vol. 13, no. 11, pp. 1307–1316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. Z. Zuo, S. Goel, and J. E. Carter, “Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth,” American Journal of Clinical Pathology, vol. 136, no. 2, pp. 260–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. J. N. Hong, E. K. Berggren, S. L. Campbell, J. S. Smith, and L. Rahangdale, “Abnormal cervical cancer screening in pregnancy and preterm delivery,” Paediatric and Perinatal Epidemiology, vol. 28, no. 4, pp. 297–301, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. Q.-T. Huang, M. Zhong, Y.-F. Gao et al., “Can HPV vaccine have other health benefits more than cancer prevention? A systematic review of association between cervical HPV infection and preterm birth,” Journal of Clinical Virology, vol. 61, no. 3, pp. 321–328, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Foresta, D. Pizzol, A. Bertoldo, M. Menegazzo, L. Barzon, and A. Garolla, “Semen washing procedures do not eliminate human papilloma virus sperm infection in infertile patients,” Fertility and Sterility, vol. 96, no. 5, pp. 1077–1082, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. M. D. Kaspersen, P. B. Larsen, H. J. Ingerslev et al., “Identification of multiple HPV types on spermatozoa from human sperm donors,” PLoS ONE, vol. 6, no. 3, Article ID e18095, 2011. View at Publisher · View at Google Scholar · View at Scopus